Public tender
Supply of the active substance mirvetuximab soravtansine for use in program B.50 for the treatment of patients with ovarian cancer.
UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE
Details
- Submission deadline
- 12. Juni 2026
- Country
- PL
- Estimated value
- PLN 6,466,000
- CPV codes
- 33652100
Documents
- Leistungsverzeichnis
- Preisblatt
- Bewerbungsbedingungen
- Vertragsbedingungen
- Anlagen und Pläne
Get started
Book a demo.
See what BOND finds for your company — tenders, suppliers, and partners you'd never discover on your own. Cancel any month, anytime.